Cargando…
Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study
BACKGROUND: Serum phosphate is a known risk factor for cardiovascular events and mortality in people with chronic kidney disease (CKD), however data on the association of these outcomes with serum phosphate in the general population are scarce. We investigate this relationship in people with and wit...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769279/ https://www.ncbi.nlm.nih.gov/pubmed/24040373 http://dx.doi.org/10.1371/journal.pone.0074996 |
_version_ | 1782283958341337088 |
---|---|
author | McGovern, Andrew Peter de Lusignan, Simon van Vlymen, Jeremy Liyanage, Harshana Tomson, Charles Richard Gallagher, Hugh Rafiq, Meena Jones, Simon |
author_facet | McGovern, Andrew Peter de Lusignan, Simon van Vlymen, Jeremy Liyanage, Harshana Tomson, Charles Richard Gallagher, Hugh Rafiq, Meena Jones, Simon |
author_sort | McGovern, Andrew Peter |
collection | PubMed |
description | BACKGROUND: Serum phosphate is a known risk factor for cardiovascular events and mortality in people with chronic kidney disease (CKD), however data on the association of these outcomes with serum phosphate in the general population are scarce. We investigate this relationship in people with and without CKD in a large community-based population. METHODS: Three groups from an adult cohort of the Quality Improvement in Chronic Kidney Disease (QICKD) cluster randomised trial (ISRCTN56023731) were followed over a period of 2.5 years: people with normal renal function (N = 24,184), people with CKD stages 1–2 (N = 20,356), and people with CKD stages 3–5 (N = 13,292). We used a multilevel logistic regression model to determine the association between serum phosphate, in these groups, and a composite outcome of all-cause mortality, cardiovascular events, and advanced coronary artery disease. We adjusted for known cardiovascular risk factors. FINDINGS: Higher phosphate levels were found to correlate with increased cardiovascular risk. In people with normal renal function and CKD stages 1–2, Phosphate levels between 1.25 and 1.50 mmol/l were associated with increased cardiovascular events; odds ratio (OR) 1.36 (95% CI 1.06–1.74; p = 0.016) in people with normal renal function and OR 1.40 (95% CI 1.09–1.81; p = 0.010) in people with CKD stages 1–2. Hypophosphatemia (<0.75 mmol/l) was associated with fewer cardiovascular events in people with normal renal function; OR 0.59 (95% CI 0.36–0.97; p = 0.049). In people with CKD stages 3–5, hyperphosphatemia (>1.50 mmol/l) was associated with increased cardiovascular risk; OR 2.34 (95% CI 1.64–3.32; p<0.001). Other phosphate ranges were not found to have a significant impact on cardiovascular events in people with CKD stages 3–5. CONCLUSIONS: Serum phosphate is associated with cardiovascular events in people with and without CKD. Further research is required to determine the mechanisms underlying these associations. |
format | Online Article Text |
id | pubmed-3769279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37692792013-09-13 Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study McGovern, Andrew Peter de Lusignan, Simon van Vlymen, Jeremy Liyanage, Harshana Tomson, Charles Richard Gallagher, Hugh Rafiq, Meena Jones, Simon PLoS One Research Article BACKGROUND: Serum phosphate is a known risk factor for cardiovascular events and mortality in people with chronic kidney disease (CKD), however data on the association of these outcomes with serum phosphate in the general population are scarce. We investigate this relationship in people with and without CKD in a large community-based population. METHODS: Three groups from an adult cohort of the Quality Improvement in Chronic Kidney Disease (QICKD) cluster randomised trial (ISRCTN56023731) were followed over a period of 2.5 years: people with normal renal function (N = 24,184), people with CKD stages 1–2 (N = 20,356), and people with CKD stages 3–5 (N = 13,292). We used a multilevel logistic regression model to determine the association between serum phosphate, in these groups, and a composite outcome of all-cause mortality, cardiovascular events, and advanced coronary artery disease. We adjusted for known cardiovascular risk factors. FINDINGS: Higher phosphate levels were found to correlate with increased cardiovascular risk. In people with normal renal function and CKD stages 1–2, Phosphate levels between 1.25 and 1.50 mmol/l were associated with increased cardiovascular events; odds ratio (OR) 1.36 (95% CI 1.06–1.74; p = 0.016) in people with normal renal function and OR 1.40 (95% CI 1.09–1.81; p = 0.010) in people with CKD stages 1–2. Hypophosphatemia (<0.75 mmol/l) was associated with fewer cardiovascular events in people with normal renal function; OR 0.59 (95% CI 0.36–0.97; p = 0.049). In people with CKD stages 3–5, hyperphosphatemia (>1.50 mmol/l) was associated with increased cardiovascular risk; OR 2.34 (95% CI 1.64–3.32; p<0.001). Other phosphate ranges were not found to have a significant impact on cardiovascular events in people with CKD stages 3–5. CONCLUSIONS: Serum phosphate is associated with cardiovascular events in people with and without CKD. Further research is required to determine the mechanisms underlying these associations. Public Library of Science 2013-09-10 /pmc/articles/PMC3769279/ /pubmed/24040373 http://dx.doi.org/10.1371/journal.pone.0074996 Text en © 2013 McGovern et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article McGovern, Andrew Peter de Lusignan, Simon van Vlymen, Jeremy Liyanage, Harshana Tomson, Charles Richard Gallagher, Hugh Rafiq, Meena Jones, Simon Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study |
title | Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study |
title_full | Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study |
title_fullStr | Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study |
title_full_unstemmed | Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study |
title_short | Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study |
title_sort | serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769279/ https://www.ncbi.nlm.nih.gov/pubmed/24040373 http://dx.doi.org/10.1371/journal.pone.0074996 |
work_keys_str_mv | AT mcgovernandrewpeter serumphosphateasariskfactorforcardiovasculareventsinpeoplewithandwithoutchronickidneydiseasealargecommunitybasedcohortstudy AT delusignansimon serumphosphateasariskfactorforcardiovasculareventsinpeoplewithandwithoutchronickidneydiseasealargecommunitybasedcohortstudy AT vanvlymenjeremy serumphosphateasariskfactorforcardiovasculareventsinpeoplewithandwithoutchronickidneydiseasealargecommunitybasedcohortstudy AT liyanageharshana serumphosphateasariskfactorforcardiovasculareventsinpeoplewithandwithoutchronickidneydiseasealargecommunitybasedcohortstudy AT tomsoncharlesrichard serumphosphateasariskfactorforcardiovasculareventsinpeoplewithandwithoutchronickidneydiseasealargecommunitybasedcohortstudy AT gallagherhugh serumphosphateasariskfactorforcardiovasculareventsinpeoplewithandwithoutchronickidneydiseasealargecommunitybasedcohortstudy AT rafiqmeena serumphosphateasariskfactorforcardiovasculareventsinpeoplewithandwithoutchronickidneydiseasealargecommunitybasedcohortstudy AT jonessimon serumphosphateasariskfactorforcardiovasculareventsinpeoplewithandwithoutchronickidneydiseasealargecommunitybasedcohortstudy |